60
Participants
Start Date
August 31, 2012
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
ID93 + GLA-SE
ID93 antigen and GLA-SE adjuvant. 3 injections at Days 0, 28, and 56.
ID93 alone
ID93 antigen alone. 3 injections and Days 0, 28, and 56.
Johnson County Clin-Trials, Lenexa
Collaborators (1)
Aeras
OTHER
Paul G. Allen Family Foundation
OTHER
Access to Advanced Health Institute (AAHI)
OTHER